Utah Medical Products, Inc. (FRA:UTM)
Germany
· Delayed Price · Currency is EUR 46.20
-0.20 (-0.43%)
Last updated: Dec 3, 2025, 8:01 AM CET
Utah Medical Products Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 11.62 | 13.87 | 16.64 | 16.47 | 14.79 | 10.8 | Upgrade
|
| Depreciation & Amortization | 2.98 | 2.85 | 6.37 | 7.08 | 7.28 | 7.21 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0 | Upgrade
|
| Stock-Based Compensation | 0.33 | 0.26 | 0.23 | 0.18 | 0.17 | 0.16 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.4 | -0 | -0.03 | 0.03 | 0.02 | -0.01 | Upgrade
|
| Other Operating Activities | -0.58 | -0.36 | -0.69 | -0.4 | -0.09 | -0.03 | Upgrade
|
| Change in Accounts Receivable | -0.63 | -0.84 | 2.27 | -0.51 | -1.09 | 0.62 | Upgrade
|
| Change in Inventory | 1.09 | 0.59 | -0.67 | -2.35 | -0.49 | 0.92 | Upgrade
|
| Change in Accounts Payable | -0.23 | -0.07 | -0.46 | 0.46 | -0.02 | -0.31 | Upgrade
|
| Change in Other Net Operating Assets | -0.83 | -1.48 | -1.38 | 0.17 | 0.59 | 0.76 | Upgrade
|
| Operating Cash Flow | 14.15 | 14.83 | 22.28 | 21.15 | 21.2 | 20.14 | Upgrade
|
| Operating Cash Flow Growth | -17.84% | -33.44% | 5.36% | -0.26% | 5.29% | 18.06% | Upgrade
|
| Capital Expenditures | -0.27 | -0.23 | -0.64 | -0.81 | -0.55 | -0.86 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.03 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.01 | - | -0.01 | - | - | Upgrade
|
| Investing Cash Flow | -0.27 | -0.21 | -0.64 | -0.82 | -0.55 | -0.86 | Upgrade
|
| Issuance of Common Stock | - | 0.39 | 0.12 | 0.17 | 0.56 | 0.36 | Upgrade
|
| Repurchase of Common Stock | -14.07 | -19.97 | - | -2.5 | - | -6.98 | Upgrade
|
| Common Dividends Paid | -4.04 | -4.26 | -4.28 | -3.16 | -11.47 | -4.12 | Upgrade
|
| Financing Cash Flow | -18.11 | -23.84 | -4.17 | -5.48 | -10.91 | -10.73 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.05 | -0.68 | 0.34 | -0.77 | -0.36 | 0.26 | Upgrade
|
| Net Cash Flow | -4.18 | -9.89 | 17.82 | 14.08 | 9.38 | 8.8 | Upgrade
|
| Free Cash Flow | 13.88 | 14.6 | 21.64 | 20.34 | 20.65 | 19.28 | Upgrade
|
| Free Cash Flow Growth | -17.94% | -32.53% | 6.41% | -1.52% | 7.13% | 16.72% | Upgrade
|
| Free Cash Flow Margin | 35.93% | 35.70% | 43.09% | 38.90% | 42.10% | 45.70% | Upgrade
|
| Free Cash Flow Per Share | 4.22 | 4.17 | 5.95 | 5.58 | 5.64 | 5.25 | Upgrade
|
| Cash Income Tax Paid | 3.78 | 4.64 | 4.83 | 4.97 | 4.62 | 3.19 | Upgrade
|
| Levered Free Cash Flow | 11.81 | 11.74 | 17.69 | 18.35 | 17.14 | 16.85 | Upgrade
|
| Unlevered Free Cash Flow | 11.81 | 11.74 | 17.69 | 18.35 | 17.14 | 16.85 | Upgrade
|
| Change in Working Capital | -0.6 | -1.8 | -0.23 | -2.23 | -1.01 | 1.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.